Journal of Neuro-Oncology

, Volume 131, Issue 3, pp 459–467 | Cite as

The inhibiting activity of meadowsweet extract on neurocarcinogenesis induced transplacentally in rats by ethylnitrosourea

  • Vladimir G. Bespalov
  • Valerij A. Alexandrov
  • Galina I. Vysochina
  • Vera А. Kostikova
  • Denis A. Baranenko
Laboratory Investigation


Inhibitory activity of a decoction of meadowsweet, given postnatally, was studied in rats at risk for neurogenic and renal tumors initiated by transplacental exposure to ethylnitrosourea (ENU). Chemical analysis of ethanol and aqueous extracts of meadowsweet has shown high content of biologically active flavonoids and tannins. Pregnant rats of LIO strain were given a single i.v. injection of ENU, 75 mg/kg, оn the 21st day of gestation. After weaning at 3 weeks after birth, the offspring were divided into two groups: the first was a positive control (ENU), while rats in the second group (ENU + meadowsweet) were given daily a decoction of meadowsweet as drinking water throughout their lifetime. All rats of the first group (ENU) developed multiple malignant tumors, which occurred in brain (86%), spinal cord (43%), peripheral and cranial nerves (29%) and in kidney (31%). More than one-third of CNS tumors were oligodendrogliomas. Mixed gliomas (oligoastrocytomas) occurred less frequently. All other types including astrocytomas, glioblastomas, and ependymomas were rare. All PNS tumors were neurinomas (schwannomas). The spectrum of tumors was similar in rats of the second group. Postnatal consumption of meadowsweet significantly reduced number of tumor-bearing rats (by 1.2 times), the incidence and multiplicity of CNS tumors (brain—by 2.0 and 2.1 times, respectively; spinal cord—by 3.1 and 3.0 times, respectively) and significantly increased latency period, compared to rats of the first group. No significant reduction in PNS or renal tumors was seen in rats given meadowsweet. Meadowsweet extract can be considered an effective cancer preventive agent especially as a neurocarcinogenesis inhibitor.


Ethylnitrosourea Neurogenic tumors Meadowsweet decoction Chemoprevention 



This work was partially financially supported by Government of Russian Federation, Grant 074-U01. The authors wish to thank Professor Jerry M. Rice, Georgetown University Medical Center, Washington, DC, USA for scientific advice and editorial suggestions on the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that there is no conflict of interest.


  1. 1.
    Kaderali Z, Lamberti-Pasculli M, Rutka JT (2009) The changing epidemiology of paediatric brain tumours: a review from the Hospital for Sick Children. Childs Nerv Syst 25:787–793CrossRefPubMedGoogle Scholar
  2. 2.
    Johnson KJ, Cullen J, Barnholtz-Sloan JS, Ostrom QT, Langer CE, Turner MC, McKean-Cowdin R, Fisher JL, Lupo PJ, Partap S, Schwartzbaum JA, Scheurer ME (2014) Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review. Cancer Epidemiol Biomarkers Prev 23:2716–2736CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Llopis-González A, Alcaide Capilla T, Chenlo Alonso U, Rubio-López N, Alegre-Martinez A, Morales Suárez-Varela M (2015) Central nervous system (CNS) cancer in children and young people in the European Union and its involvements with socio-economic and environmental factors. J Neurol Sci 359:151–155CrossRefPubMedGoogle Scholar
  4. 4.
    Serrano D, Lazzeroni M, Bonanni B (2015) Cancer chemoprevention: much has been done, but there is still much to do. State of the art and possible new approaches. Mol Oncol 9:1008–1017CrossRefPubMedGoogle Scholar
  5. 5.
    Shoemaker RH, Suen CS, Holmes CA, Fay JR, Steele VE (2016) The National Cancer Institute’s PREVENT cancer preclinical drug development program: overview, current projects, animal models, agent development strategies, and molecular targets. Semin Oncol 43:189–197CrossRefPubMedGoogle Scholar
  6. 6.
    Ivankovic S, Druckrey H (1968) Transplacental induction of malignant tumors of the nervous system. I. Ethyl-nitroso-urea (ENU) in BD IX rats. Z Krebsforsch 71:320–360 (in German)CrossRefPubMedGoogle Scholar
  7. 7.
    Swenberg JA, Koestner A, Wechsler W, Denlinger RH (1972) Quantitative aspects of transplacental tumor induction with ethylnitrosourea in rats. Cancer Res 32:2656–2660PubMedGoogle Scholar
  8. 8.
    Lantos PL (1986) Development of nitrosourea-induced brain tumours–with a special note on changes occurring during latency. Food Chem Toxicol 24:121–127CrossRefPubMedGoogle Scholar
  9. 9.
    Alexandrov VA, Bespalov VG, Boone CB, Kelloff GJ, Malony WF (1991) Study of postnatal effects of chemopreventive agents on offspring of ethylnitrosourea-induced transplacental carcinogenesis in rats. I. Influence of retinol acetate, alpha-tocopherol acetate, thiamine chloride, sodium selenite, and alpha-difluoromethylornithine. Cancer Lett 60:177–184CrossRefPubMedGoogle Scholar
  10. 10.
    Alexandrov VA, Bespalov VG, Morozov VG, Khavinson VKh, Anisimov VN (1996a) Study of the post-natal effects of chemopreventive agents on ethylnitrosourea-induced transplacental carcinogenesis in rats. II. Influence of low-molecular-weight polypeptide factors from the thymus, pineal gland, bone marrow, anterior hypothalamus, brain cortex and brain white substance. Carcinogenesis 17:1931–1934CrossRefPubMedGoogle Scholar
  11. 11.
    Alexandrov VA, Bespalov VG, Petrov AS, Troyan DN, Lidaks MYu (1996b) Study of the post-natal effects of chemopreventive agents on ethylnitrosourea-induced transplacental carcinogenesis in rats. III. Inhibitory action of indomethacin, voltaren, theophylline and epsilon-aminocaproic acid. Carcinogenesis 17:1935–1939CrossRefPubMedGoogle Scholar
  12. 12.
    Vogl S, Picker P, Mihaly-Biso J, Fakhrudin N, Atanasov AG, Heiss EH, Wawrosch C, Reznicek G, Dirsch VM, Saukel J, Kopp B (2013) Ethnopharmacological in vitro studies on Austria’s folk medicine: an unexplored lore in vitro anti-inflammatory activities of 71 Austrian traditional herbal drugs. J Ethnopharmacol 149:750–771CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Barros L, Alves CT, Duenas M, Silva S, Oliveira R, Carvalho AM, Henriques M, Santos-Buelga C, Ferreira IC (2013) Characterization of phenolic compounds in wild medicinal flowers from Portugal by HPLC-DAD-ESI/MS and evaluation of antifungal properties. Ind Crops Prod 44:104–110CrossRefGoogle Scholar
  14. 14.
    Katanić J, Boroja T, Stanković N, Mihailović V, Mladenović M, Kreft S, Vrvić MM (2015) Bioactivity, stability and phenolic characterization of Filipendula ulmaria (L) Maxim. Food Funct 6:1164–1175CrossRefPubMedGoogle Scholar
  15. 15.
    Denev P, Kratchanova M, Ciz M, Lojek A, Vasicek O, Blazheva D, Nedelcheva P, Vojtek L, Hyrsl P (2014) Antioxidant, antimicrobial and neutrophil-modulating activities of herb extracts. Acta Biochim Pol 61:359–367PubMedGoogle Scholar
  16. 16.
    European Medicines Agency (2015) Assessment report on Filipendula ulmaria (L.) Maxim., herba and Filipendula ulmaria (L.) Maxim. flos. Available at Accessed 20 July 2016
  17. 17.
    Shu L, Cheung K-L, Khor TO, Kong A-N (2010) Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis. Cancer Metastasis Rev 29:483–502CrossRefPubMedGoogle Scholar
  18. 18.
    Thakur VS, Deb G, Babcook MA, Gupta S (2014) Plant phytochemicals as epigenetic modulators: role in cancer chemoprevention. AAPS J 16:151–163CrossRefPubMedGoogle Scholar
  19. 19.
    Woisky R, Salatino A (1998) Analysis of propolis: some parameters and procedures for chemical quality control. J Apic Res 37:99–105CrossRefGoogle Scholar
  20. 20.
    Butler LG, Price MC, Brotherton JE (1982) Vanillin assay for proanthocyanidins (condensed tannins): modification of solvent for estimation of the degree of polymerization. J Agricult Food Chem 30:1087–1089CrossRefGoogle Scholar
  21. 21.
    Oktyabrsky O, Vysochina G, Muzyka N, Samoilova Z, Kukushkina T, Smirnova G (2009) Assessment of anti-oxidant activity of plant extracts using microbial test systems. J Appl Microbiol 106:1175–1183CrossRefPubMedGoogle Scholar
  22. 22.
    van Beek TA (2002) Chemical analysis of Ginkgo biloba leaves and extracts. J Chromatogr A 967:21–35CrossRefPubMedGoogle Scholar
  23. 23.
    Anisimov VN, Ukraintseva SV, Anikin IV, Popovich IG, Zabezhinski MA, Bertsein LM, Arutjunyan AV, Ingram DK, Lane MA, Roth GS (2005) Effects of phentermine and phenformin on biomarkers of aging in rats. Gerontology 51(1):19–28CrossRefPubMedGoogle Scholar
  24. 24.
    Turusov VS, Mohr U (eds) (1990) Pathology of tumors in laboratory animals. Tumors of the Rat. Vol. 1, 2nd edn. IARC Sci Publ No. 99. IARC, LyonGoogle Scholar
  25. 25.
    Fecka I (2009) Qualitative and quantitative determination of hydrolysable tannins and other polyphenols in herbal products from meadowsweet and dog rose. Phytochem Analysis 20:177–190CrossRefGoogle Scholar
  26. 26.
    Druckrey H, Landschütz C, Ivankovic S (1970) Transplacental induction of malignant tumours of the nervous system. II. Ethyl-nitrosurea in 10 genetically defined strains of rats. Z Krebsforsch 73:371–386 (in German)CrossRefPubMedGoogle Scholar
  27. 27.
    Koestner A, Swenberg JA, Wechsler W (1972) Experimental tumors of the nervous system induced by resorptive N-nitrosourea compounds. Prog Exp Tumor Res 17:9–30CrossRefPubMedGoogle Scholar
  28. 28.
    Koestner A, Swenberg JA, Denlinger RH (1979) Host factors affecting perinatal carcinogenesis by resorptive alkylnitrosoureas in rats. In: Rice JM (ed) Perinatal Carcinigenesis, Nat Cancer Inst Monogr 51. NCI, Bethesda, pp 211–217Google Scholar
  29. 29.
    Zook BC, Simmens SJ, Jones RV (2000) Evaluation of ENU-induced gliomas in rats: nomenclature, immunochemistry, and malignancy. Toxicol Pathol 28:193–201CrossRefPubMedGoogle Scholar
  30. 30.
    Bertrand L, Mukaratirwa S, Bradley A (2014) Incidence of spontaneous central nervous system tumors in CD-1 mice and Sprague-Dawley, Han-Wistar, and Wistar rats used in carcinogenicity studies. Toxicol Pathol 42:1168–1173CrossRefPubMedGoogle Scholar
  31. 31.
    Vinogradova IA, Anisimov VN, Bukalev AV, Semenchenko AV, Zabezhinski MA (2009) Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in rats. Aging 1:855–865CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Goth R, Rajewsky MF (1974) Molecular and cellular mechanisms associated with pulse-carcinogenesis in the rat nervous system by ethyinitrosourea: ethylation of nucleic acids and elimination rates of ethylated bases from the DNA of different tissues. Z Krebsforsch 82:37–64CrossRefGoogle Scholar
  33. 33.
    Chang MJ, Koestner A, Hart RW (1981) Interrelationships between cellular proliferation, DNA alkylation and age as determinants of ethylnitrosourea-induced neoplasia. Cancer Lett 13:39–45CrossRefPubMedGoogle Scholar
  34. 34.
    Müller R, Rajewsky MF (1983) Elimination of O6-ethylguanine from the DNA of brain, liver, and other rat tissues exposed to ethylnitrosourea at different stages of prenatal development. Cancer Res 43:2897–2904PubMedGoogle Scholar
  35. 35.
    Perantoni AO, Rice JM, Reed CD, Watatani M, Wenk ML (1987) Activated neu oncogene sequences in primary tumors of the peripheral nervous system induced in rats by transplacental exposure to ethylnitrosourea. Proc Natl Acad Sci USA 84:6317–6321CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Yamasaki H, Hollstein M, Marte lN, Cabral JR, Galendo D, Tomatis L (1987) Transplacental induction of a specific mutation in fetal Ha-ras and its critical role in post-natal carcinogenesis. Int J Cancer 40:818–822CrossRefPubMedGoogle Scholar
  37. 37.
    Brüstle O, Ohgaki H, Schmitt HP, Walter GF, Ostertag H, Kleihues P (1992) Primitive neuroectodermal tumors after prophylactic central nervous system irradiation in children. Association with an activated K-ras gene. Cancer 69:2385–2392CrossRefPubMedGoogle Scholar
  38. 38.
    Rice JM (2006) Inducible and transmissible genetic events and pediatric tumors of the nervous system. J Radiat Res 47(Suppl):B1–B11CrossRefPubMedGoogle Scholar
  39. 39.
    Popovich IG, Alexandrov VA, Anisimov VN, Napalkov NP (1989) Influеnce of hormonal disturbances on transplacental and multigeneration carcinogenesis in rats. In: Napalkov NP, Rice JM et al (eds) Perinatal and multigeneration carcinogenesis, IARC Sci Publ No. 96. IARC, Lyon, pp 35–49Google Scholar
  40. 40.
    Berstein LM, Alexandrov VA (1989) Fetal macrosomia and sex differences in the influence of modifying factors on transplacental carcinogenesis. In: Napalkov NP, Rice JM et al (eds) Perinatal and multigeneration carcinogenesis, IARC Sci Publ No. 96. IARC, Lyon, pp 57–61Google Scholar
  41. 41.
    Alexandrov V, Aiello C, Rossi L (1990) Modifying factors in prenatal carcinogenesis (review). In Vivo 4:327–336PubMedGoogle Scholar
  42. 42.
    Su ZY, Shu L, Khor TO, Lee JH, Fuentes F, Kong AN (2013) A perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomics. Top Curr Chem 329:133–162CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Ramos S (2008) Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 52:507–526CrossRefPubMedGoogle Scholar
  44. 44.
    Bespalov VG, Alexandrov VA (1985) The influence of anticarcinogenic substances on the transplacental carcinogenic effect of N-ethyl-N-nitrosourea. Voprosy Oncologii 7:73–76 (in Russian)Google Scholar
  45. 45.
    Morozov VG, Khavinson WKh (1983) Cytomediators as a new class of biological regulators of multicellular system. Usp Sovrem Biol 96:339–352 (in Russian)Google Scholar
  46. 46.
    Raju NR, Koestner A, Marushige K, Lovell KL, Okazaki D (1989) Effect of nerve growth factor on the transplacental induction of neurinomas by ethylnitrosourea in Sprague-Dawley rats. Cancer Res 49:7120–7123PubMedGoogle Scholar
  47. 47.
    Reyes S, Rembao D, Sotelo J (2001) The antimalarials quinacrine and chloroquine potentiate the transplacental carcinogenic effect of ethylnitrosourea on ependymal cells. Brain Tumor Pathol 18:83–87CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Vladimir G. Bespalov
    • 1
    • 3
  • Valerij A. Alexandrov
    • 1
    • 3
  • Galina I. Vysochina
    • 2
  • Vera А. Kostikova
    • 2
  • Denis A. Baranenko
    • 3
  1. 1.Laboratory of Cancer Chemoprevention and OncopharmacologyN.N. Petrov Research Institute of Oncology of the Ministry of Health of the Russian FederationSaint PetersburgRussia
  2. 2.Central Siberian Botanical GardenSiberian Division of the Russian Academy of SciencesNovosibirskRussia
  3. 3.International Research Centre “Biotechnologies of the Third Millennium”ITMO UniversitySaint PetersburgRussia

Personalised recommendations